Small Molecule Inhibitor Shows Promise in Resistant Ovarian Cancer Responses in 37% of patients with AVB-500, higher without prior bevacizumab Mar 21, 2021
Is MIS Viable for Interval Debulking in Ovarian Cancer? Retrospective study compared approach versus open surgery after neoadjuvant chemotherapy Mar 21, 2021
PARP Inhibitor Tops Chemo for Recurrent BRCA Ovarian Cancer Modest improvement in PFS with rucaparib but worse outcome for reversion mutation Mar 20, 2021
New Targeted Therapies Show Promise in Cancer Selected abstracts from the ESMO Targeted Anticancer Therapies virtual meeting Mar 03, 2021
Kardashian Makeup Artist Hrush Achemyan's Ovarian Cancer Beauty influencer reveals diagnosis Jan 21, 2021
PARP Inhibitors Linked With Blood Cancer Risk Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
Immunotherapy Falls Short Again in Ovarian Cancer No PFS benefit in advanced disease with addition of atezolizumab to chemo, bevacizumab Sep 23, 2020
Which Women Choose Hormones for Surgical Menopause? Understanding patterns of use can help improve targeting for education and counseling, researchers say Aug 12, 2020
Second Surgery Gets OS Win in Recurrent Ovarian Cancer Survival improved by nearly 8 months with cytoreductive surgery at first relapse Jun 02, 2020
Avelumab Flops Again in Ovarian Cancer Another negative phase III trial, now in the first-line setting May 19, 2020
PARP Inhibitors Still Work in HRD-Low Ovarian Cancer In VELIA, homologous recombination deficiency score prognostic but not predictive May 14, 2020
KRAS May Predict Benefit of MEK Inhibitors in Some Ovarian Cancers Nearly 7-month PFS boost in patients with KRAS mutations May 11, 2020
New Standard in Recurrent, Platinum-Sensitive Ovarian Cancer Pegylated liposomal doxorubicin unseats gemcitabine in standard platinum regimen Apr 21, 2020
Breastfeeding Tied to Lower Ovarian Cancer Risk Lower incidence of borderline tumors as well Apr 02, 2020
Post-Op HPV Vaccine Cuts Cervical Precancer Recurrences Plus osteoporosis in gynecologic cancer survivors, and a novel approach to CIN2/3 Mar 31, 2020
DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
After Five Months in a Coma, Young Nurse Wakes Up Chicago RN with rare autoimmune encephalitis responds to unusual treatment Jan 10, 2020
Trametinib Tx Shows Promise in Tough-to-Treat LGSOC Targeted drug provokes good response in chemoresistant, low-grade serous ovarian or peritoneal cancer Sep 30, 2019
Data Support 'Best Drug First' in EGFR-Mutant NSCLC Six-month survival gain with osimertinib, adding to PFS, safety advantages Sep 29, 2019
PARP Inhibitors: The Key to a Tx Paradigm Shift in Ovarian Ca? PRIMA and VELIA trial findings advance niraparib and veliparib to the therapeutic front lines Sep 29, 2019
First-Line Combo Boosts PFS in Advanced Ovarian Ca Olaparib-bevacizumab maintenance boosts PARP inhibitor benefits beyond BRCA-mutated subgroup Sep 28, 2019
Obamacare Cut Racial Disparities in Cancer Care Time to cancer treatment evens in blacks and whites with Medicaid expansion Jun 03, 2019
Birth Control Pills Tied to Reduced Risk of Deadly Ovarian Ca Every 5 years of use linked with 32% reduction in risk of dying within 12 months of diagnosis Apr 04, 2019 video
Early Data Send Strong Signal in Advanced Gyn Cancers Clinical benefit rate tops 90% in pair of single-center studies Mar 19, 2019
'End of the Road' for Trabectedin in Ovarian Cancer? Trial stopped for futility, but 13-month OS improvement seen in patients with BRCA mutations Mar 19, 2019
When PARP Inhibitors Fail in Ovarian Cancer Study identifies subgroup for whom another go could be worthwhile Mar 18, 2019
Avelumab Combo Falls Short in Advanced Ovarian Ca But showed promise in PD-L1-positive group Mar 18, 2019
PARP Inhibitor Benefit Gets a TWiST in Recurrent Ovarian Ca Analysis attempts to quantify patients' quality of survival Mar 17, 2019
Lymphadenectomy Often Useless in Ovarian Cancer No survival benefit with normal nodes after complete macroscopic resection Mar 01, 2019
Surgery/HIPEC Safer Than Other High-Risk Cancer Procedures Lower infection, 30-day mortality rates than with Whipple, esophagectomy Jan 15, 2019
Does Johnson's Baby Powder Cause Cancer? Milton Packer says the $4.69-billion verdict is about anger, not medicine Jan 09, 2019
Simple Ovarian Cysts Hold No Cancer Risk Malignancy extremely rare, don't need surveillance Nov 12, 2018
Practice-Changing PARP Inhibitor Study in Ovarian Cancer "Unprecedented" increase in PFS with upfront olaparib maintenance Oct 21, 2018
Serena Williams: Women's Healthcare Hero? Yes! She's a champ on the tennis court and could prevent maternal death Aug 02, 2018
Cancer Linked to Infertility in Men and Women Assisted reproductive technology not to blame, researchers say Jul 03, 2018
PFS Rises in Ovarian Ca with Repeat Bevacizumab Magnitude of benefit similar to first-line therapy Jun 06, 2018
Women Do Well Without Opioids after Gyn Surgery An 89% drop in opioid use with restrictive prescribing protocol Mar 26, 2018
Gyn Cancer Research Gets Short Shrift in Funding Mortality-adjusted analysis shows huge disparity versus other cancers Mar 25, 2018
Possible Chlamydia Link with Ovarian Cancer Associations seen in two separate cohorts of women Mar 19, 2018
Telemedicine OK for Genetic Testing and Counseling Trial finds no major difference in psychosocial outcomes Aug 09, 2017
